These behavioral abnormalities were improved by RU-486 (an antagonist for corticosterone) or Ab4B19 (an agonistic antibody for TrkB), suggesting both environmental and genetic factors contributing to the pathogenesis of schizophrenia [16]. This evidence concerns the gene NTRK2 and schizophrenia.